0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Stephen J. Russell
QNB Bank
1 follower
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)
1 follower
Alvarez & Marsal
46 followers
4D Molecular Therapeutics
3 followers
The Boring Company
35 followers
Temu
27 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Jeeves
5 followers
Immunome
2 followers
Cytokinetics
11 followers
Explore companies